The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Risk Factors for Lymphedema after Breast Cancer Treatment
Open accessAbstract
Background: As cancer treatments evolve, it is important to reevaluate their effect on lymphedema risk in breast cancer survivors. Methods: A population-based random sample of 631 women from metropolitan Philadelphia, Pennsylvania, diagnosed with incident breast cancer in 1999 to 2001, was followed for 5 years. Risk factor information was obtained by questionnaire and medical record review. Lymphedema was assessed with a validated questionnaire. Using Cox proportional hazards models, we estimated the relative incidence rates [hazard ratios (HR)] of lymphedema with standard adjusted multivariable analyses ignoring interactions, followed by models including clinically plausible treatment interactions. Results: Compared with no lymph node surgery, adjusted HRs for lymphedema were increased following axillary lymph node dissection [ALND; HR, 2.61; 95% confidence interval (95% CI), 1.77-3.84] but not sentinel lymph node biopsy (SLNB; HR, 1.04; 95% CI, 0.58-1.88). Risk was not increased following irradiation [breast/chest wall only: HR, 1.18 (95% CI, 0.80-1.73); breast/chest wall plus supraclavicular field (+/− full axilla): HR, 0.86 (95% CI, 0.48-1.54)]. Eighty-one percent of chemotherapy was anthracycline based. The HR for anthracycline chemotherapy versus no chemotherapy was 1.46 (95% CI, 1.04-2.04), persisting after stratifying on stage at diagnosis or number of positive nodes. Treatment combinations involving ALND or chemotherapy resulted in approximately 4- to 5-fold increases in HRs for lymphedema [e.g., HR of 4.16 (95% CI, 1.32-12.45) for SLNB/chemotherapy/no radiation] compared with no treatment. Conclusion: With standard multivariable analyses, ALND and chemotherapy increased lymphedema risk whereas radiation therapy and SLNB did not. However, risk varied by combinations of exposures. Impact: Treatment patterns should be considered when counseling and monitoring patients for lymphedema. Cancer Epidemiol Biomarkers Prev; 19(11); 2734–46. ©2010 AACR.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Arm edema in breast cancer patients
Erickson, V. S., Pearson, M. L., Ganz, P. A., Adams, J., & Kahn, K. L. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.2.96 · Cited by 560
Lymphedema: current issues in research and management
Petrek, J. A., Pressman, P. I., & Smith, R. A. (2000) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.50.5.292 · Cited by 283
Cited by
Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis
DiSipio, T., Rye, S., Newman, B., & Hayes, S. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70076-7 · Cited by 1,885
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A., Elias, A. D., Farrar, W. B., Forero, A., Giordano, S. H., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0012 · Cited by 1,609
Bodai, B. I., & Tuso, P. (2015) · The Permanente Journal · doi:10.7812/tpp/14-241 · Cited by 397
Breast cancer-related lymphedema: risk factors, precautionary measures, and treatments
Gillespie, T. C., Sayegh, H. E., Brunelle, C. L., Daniell, K. M., & Taghian, A. G. (2018) · Gland Surgery · doi:10.21037/gs.2017.11.04 · Cited by 361
Lymphedema following breast cancer treatment and impact on quality of life: A review
Taghian, N. R., Miller, C. L., Jammallo, L. S., O’Toole, J., & Skolny, M. N. (2014) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2014.06.004 · Cited by 333
Metadata
- Authors
- Norman, S. A., Localio, A. R., Kallan, M. J., Weber, A. L., Simoes Torpey, H. A., Potashnik, S. L., Miller, L. T., Fox, K. R., DeMichele, A., & Solin, L. J.
- Venue
- Cancer Epidemiology, Biomarkers & Prevention
- Published
- 2010-11-01
- Volume
- 19
- Issue
- 11
- Pages
- 2734-2746
- ISSN
- 1055-9965 (ISSN-L)
- 1538-7755
- OpenAlex
- W2167484859
- Cited by
- 160
- References
- 2
- FWCI
- 5.27
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Risk Factors for Lymphedema after Breast Cancer Treatment. https://app.cochat.ai/papers/10.1158/1055-9965.epi-09-1245
- The paper
- Norman, S. A., Localio, A. R., Kallan, M. J., Weber, A. L., Simoes Torpey, H. A., Potashnik, S. L., Miller, L. T., Fox, K. R., DeMichele, A., & Solin, L. J. (2010). Risk Factors for Lymphedema after Breast Cancer Treatment. Cancer Epidemiology, Biomarkers & Prevention. https://doi.org/10.1158/1055-9965.epi-09-1245
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.